Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chemical Record (New York, N.Y.)|November 24, 2021
Pharmacological Chaperones for β-Galactosidase Related to GM1 -Gangliosidosis and Morquio B: Recent AdvancesArnold E Stütz, Martin Thonhofer, Patrick Weber, et al.
Carbohydrate Research|November 10, 2016
From secondary alcohols to tertiary fluoro substituents: A simple route to hydroxymethyl branched sugars with a fluorine substituent at the branching pointMichael Schalli, Martin Thonhofer, Andreas Wolfsgruber, et al.
Carbohydrate Research|January 31, 2017
C-5a-substituted validamine type glycosidase inhibitorsMichael Schalli, Andreas Wolfsgruber, Andres Gonzalez Santana, et al.
Monatshefte Fur Chemie|June 11, 2019
Synthesis of modified 1,5-imino-d-xylitols as ligands for lysosomal β-glucocerebrosidaseManuel Zoidl, Andreas Wolfsgruber, Michael Schalli, et al.
RSC Advances|April 28, 2022
New α-galactosidase-inhibiting aminohydroxycyclopentanesPatrick Weber, Roland Fischer, Seyed A Nasseri, et al.
Molecules (Basel, Switzerland)|October 14, 2020
N-Alkylated Iminosugar Based Ligands: Synthesis and Inhibition of Human Lysosomal β-GlucocerebrosidaseAndreas Wolfsgruber, Martin Thonhofer, Patrick Weber, et al.
Bioorganic Chemistry|September 4, 2023
Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcasePatrick Weber, Zuzana Mészáros, Pavla Bojarová, et al.
Chembiochem : a European Journal of Chemical Biology|September 16, 2023
Ligand-Directed Chemistry on Glycoside Hydrolases - A Proof of Concept StudyHerwig Prasch, Andreas Wolfsgruber, Martin Thonhofer, et al.
Molecules (Basel, Switzerland)|September 9, 2020
Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and C-5a-Substituted Derivatives of 4-epi-IsofagominePatrick Weber, Martin Thonhofer, Summer Averill, et al.
Pageof 1